Overcoming Regulatory and CMC Technical Challenges of Microbiome Product Development

In this white paper we provide a fleeting look at some of the CMC ‘building blocks’ that can be assembled for moving a microbiome product from R&D into first into human studies.

Tim Adetona, M.Sc., D.PH Director, Drugs & Nutraceuticals

Tim Adetona is the Director, Regulatory Science, Drugs, Nutritionals & Nutraceuticals at VCLS. He is responsible for various life-science products regulatory authorizations including drugs, biologics and innovative nutritional products in Europe, Switzerland, US and emerging markets.

View Profile

Download the whitepaper now